|No.8 Jinshun Road Zhuqiao Pudong New District,Shanghai,Chinafirstname.lastname@example.org|
|Place of Origin:||Shanghai|
|Minimum Order Quantity:||10vials|
|Packaging Details:||Plastic Vial(Dedicated for Peptide Packing) or Glass|
|Delivery Time:||3~7 days|
|Payment Terms:||L/C, D/A, D/P, T/T, , MoneyGram|
|Supply Ability:||1000kg per month|
peptides bodybuilding supplements,
|Packing||Foil bag or tin|
|Appearance||White crystalline powder|
|Appearance||White Crystalline Powder|
|Total Plate Count||≤1000cfu/g|
|Yeast & Mold||≤100cfu/g|
|Conclusion||The product conforms to the standard.|
Main treatment: Sexual impotence, skin cancer.
During the research, people found the side effects of Melanotan II that has black skin, enhance the vitality and suppress the appetite, so, although Meilanuotan not through the America food and Drug Administration approval, but it has been a lot of women abused as a weight loss drug.Melanotan II.
A Potential Treatment for Skin Cancer:
It is known that the effects of α-MSH are mediated by melanocortin receptors.
MC1R is expressed in skin cells and has a high affinity for α-MSH and is the main receptor by which α-MSH signals.
Based on this fundamental information and observations of how α-MSH impacts melanomic cells, one study has hypothesized that "α-MSH acts initially to reduce initial tumor spread, but paradoxically protects those cells that escape from the primary tumor.
As an analog of α-MSH, it is logical to believe that Melanotan II may have similar effects.
Treatment for Male and Female Sexual Dysfunction:
Melanotan-1, the precusor to Melanotan II, would eventually be licensed for commercialization as a tanning agent and has been in development for use as a potential "therapeutic tan," with minimal need for prolonged sun exposure. In the initial clinical testing of Melanotan II, an immediate and unexpected response was noted. The main subject experienced an erection shortly after administration. It was suggested that Melanotan II "may prove equally effective in women" as a "treatment of female sexual dysfunction. At least one study has observed that administration of Melanotan II may increase sexual desire, which should warrant further "investigation of centrally acting agents on disorders of sexual desire.
Theoretically, Melanotan II may enhance sexual function in males (erectile activity) and females (increased levels of sexual desire and genital arousal). Unlike other sexual-enhancement drugs, it is hypothesizedd that Melanotan II works at a neurological level, eliciting a more "natural" sexual response with minimal side effects. It was suggested that Melanotan II "may prove equally effective in women" as a "treatment of female sexual dysfunction. At least one study has observed that administration of Melanotan II may increase sexual desire, which should warrant further "investigation of centrally acting agents on disorders of sexual desire.
Melanotan 2 is a synthetic peptide that studies have demonstrated to exhibit potent tanning (melanogenesis) and libido enhancing effects. Melanotan II is a variant of alpha-melanocyte stimulating hormone (α-MSH), a melanocortin peptide hormone which is produced naturally in the body. Structurally, Melanotan II is a cyclic heptapeptide analog of the alpha-melanocyte stimulating hormone (α-MSH) that tends to induce skin tanning. Melanotan II has the additional effect of increasing libido naturally through stimulation of the melanocortin receptors.
Melanotan 2 has been shown in studies to exhibit appetite suppressant, lipolytic, and libido-enhancing effects in addition to promoting skin tanning. Melanotan 2 has been researched extensively for use in protecting against the harmful effects of ultraviolet radiation from sunlight due to its melanogenesis-stimulating properties.
Melanotan II Listeni/mlæntæn/ developed at the University of Arizona is a synthetic analog of the naturally occurring melanocortin peptide hormone alpha-melanocyte stimulating hormone (α-MSH) that in usage has been shown to have melanogenesis (tanning) and aphrodisiac effects in preliminary studies and clinical trials. It is a cyclic lactam analog of α-MSH with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2.
Contact Person: Qin